We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Documenting Biospecimen Conditions in Reports of Studies

James A. Robb, MD; Helen M. Moore, PhD; Carolyn C. Compton, MD, PhD
JAMA. 2008;300(6):650-651. doi:10.1001/jama.300.6.650-c.
Text Size: A A A
Published online


To the Editor: The study of breast cancer gene expression signatures by Dr Acharya and colleagues1 provides the type of information needed to further the goals of personalized molecular medicine. However, the validation of such findings by other researchers is necessary before this type of information can be clinically useful. One of the major problems in validating such studies is the lack of a detailed description of how the biospecimens, which are the foundation of these molecular studies, were collected, transported, preserved, processed, and stored for the actual testing.2 This information was not provided in the article. An investigation of the references and Gene Expression Omnibus (GEO) records3 for the 5 data sets used in the study indicated that 2 did not supply any information about the tumor tissues from which the RNA was isolated for study, 2 gave basic information that the tissue was frozen, and 1 gave detailed information as to freezing and storage conditions.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




August 13, 2008
Chaitanya R. Acharya, MS; Anil Potti, MD
JAMA. 2008;300(6):650-651. doi:10.1001/jama.300.6.651.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.